Invesco Ltd. Collegium Pharmaceutical, Inc Transaction History
Invesco Ltd.
- $503 Billion
- Q1 2025
A detailed history of Invesco Ltd. transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Invesco Ltd. holds 1,632,339 shares of COLL stock, worth $52.7 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,632,339
Previous 1,775,760
8.08%
Holding current value
$52.7 Million
Previous $50.9 Million
4.23%
% of portfolio
0.01%
Previous 0.01%
Shares
25 transactions
Others Institutions Holding COLL
# of Institutions
253Shares Held
37.2MCall Options Held
61.1KPut Options Held
5.8K-
Black Rock Inc. New York, NY5.79MShares$187 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY3MShares$96.8 Million2.57% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.64MShares$85.2 Million1.67% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.25MShares$72.5 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.62MShares$52.1 Million0.08% of portfolio
About COLLEGIUM PHARMACEUTICAL, INC
- Ticker COLL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 34,126,200
- Market Cap $1.1B
- Description
- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...